News
The Hardest Job in Biopharma? The Vice President of Market Access ...
The Hardest Job in Biopharma? The Vice President of Market Access ...
The Hardest Job in Biopharma? The Vice President of Market Access ...
The Hardest Job in Biopharma? The Vice President of Market Access ...
The Hardest Job in Biopharma? The Vice President of Market Access ...
Beyond technology, regulations weigh heavily on the minds of pharma executives. Four out of 10 leaders believe regulatory ...
The Avmapki Fakzynja Co-Pack marks the first FDA-approved treatment for adult patients with KRAS-mutated recurrent low-grade ...
Josh Marsh, Vice President and General Manager of Cardinal Health Sonexus™ Access and Patient Support, outlines the recent shift in the patient services industry towards a hybrid hub model for ...
Lilly announced several changes to its executive leadership team. 1 These changes are mostly related to the company’s ...
Gilead’s Livdelzi Shows Lasting Efficacy in Primary Biliary Cholangitis, Regardless of Prior Therapy
Interim results from the ongoing Phase III ASSURE trial demonstrated that Livdelzi maintained a consistent biochemical ...
The use of RWD data in place of placebo groups is improving various elements across the clinical trial space.
In an effort to combat the state’s shortage of primary care physicians, Blue Cross Blue Shield of Massachusetts is offering ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback